Danyelza 73042-0201-01

Generic: Naxitamab

Package NDC

73042-0201-01

Manufacturer: Y-Mabs Therapeutics, Inc.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: November 25, 2020
Listing Expires: December 31, 2026
Application: BLA761171

Need to source Danyelza? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Naxitamab	40 mg/10mL

Drug Class

Glycolipid Disialoganglioside-directed Antibody [EPC]Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]Glycolipid Disialoganglioside-directed Antibody [EPC]

Selected Package

73042-0201-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (73042-201-01) / 10 mL in 1 VIAL, SINGLE-DOSE